NCT00749333View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Healthy Volunteer
Interventions
DRUG

AZD8566

solution. Specific dose will be selected by the safety review committee

DRUG

Placebo

Single 10ml oral solution.

Trial Locations (1)

Unknown

Research Site, Nottingham

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY